Skip to main content
. 2024 Oct 16;6(4):521–530. doi: 10.34067/KID.0000000621

Figure 1.

Figure 1

SGLT2 protein with TM domains defined by AA#.31 Graphed are all known protein altering pathogenic/likely pathogenic variants (blue)9,10 and novel variants associated with renal or all glucosuria (red). *Variants studied in the prospective trial. AA#, amino acid number; SGLT2, sodium-glucose cotransporter-2; TM, transmembrane.